Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

SEC Filing Details

Document Details

Filing Date
Jun 21, 2018
Document Date
Jun 21, 2018
Form Description
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Group
Registration Statements
Company
electroCore
Issuer
electroCore, Inc.